グランツマン血小板無力症治療薬の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2259)
◆英語タイトル:Global Glanzmann Thrombasthenia Therapeutic Drug Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2259
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:109
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、グランツマン血小板無力症治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(血小板輸血、組換え活性化第VII因子、抗線溶薬、フィブリンシーラント、トロンビン、デスモプレシン)、用途別市場規模(病院、診療所、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・グランツマン血小板無力症治療薬の市場動向
・企業の競争状況、市場シェア
・グランツマン血小板無力症治療薬の種類別市場規模(血小板輸血、組換え活性化第VII因子、抗線溶薬、フィブリンシーラント、トロンビン、デスモプレシン)
・グランツマン血小板無力症治療薬の用途別市場規模(病院、診療所、その他)
・グランツマン血小板無力症治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・グランツマン血小板無力症治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・グランツマン血小板無力症治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・グランツマン血小板無力症治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・グランツマン血小板無力症治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Novo Nordisk、Alnylam Pharmaceuticals、Shire (Takeda)、Biogen、Bioverativ (Sanofi)、Bayer、CSL Behring、Grifols、Bristol-Myers Squibb、Pfizer)
・結論
【レポートの概要】

Market Analysis and Insights: Global Glanzmann Thrombasthenia Therapeutic Drug Market
The global Glanzmann Thrombasthenia Therapeutic Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glanzmann Thrombasthenia Therapeutic Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glanzmann Thrombasthenia Therapeutic Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glanzmann Thrombasthenia Therapeutic Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glanzmann Thrombasthenia Therapeutic Drug market.

Global Glanzmann Thrombasthenia Therapeutic Drug Scope and Market Size
Glanzmann Thrombasthenia Therapeutic Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glanzmann Thrombasthenia Therapeutic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Platelet Transfusion
Recombinant Activated Factor VII
Antifibrinolytics
Fibrin Sealants
Thrombin
Desmopressin

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novo Nordisk
Alnylam Pharmaceuticals
Shire (Takeda)
Biogen
Bioverativ (Sanofi)
Bayer
CSL Behring
Grifols
Bristol-Myers Squibb
Pfizer

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Platelet Transfusion
1.2.3 Recombinant Activated Factor VII
1.2.4 Antifibrinolytics
1.2.5 Fibrin Sealants
1.2.6 Thrombin
1.2.7 Desmopressin
1.3 Market by Application
1.3.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Perspective (2016-2027)
2.2 Glanzmann Thrombasthenia Therapeutic Drug Growth Trends by Regions
2.2.1 Glanzmann Thrombasthenia Therapeutic Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Glanzmann Thrombasthenia Therapeutic Drug Historic Market Share by Regions (2016-2021)
2.2.3 Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Regions (2022-2027)
2.3 Glanzmann Thrombasthenia Therapeutic Drug Industry Dynamic
2.3.1 Glanzmann Thrombasthenia Therapeutic Drug Market Trends
2.3.2 Glanzmann Thrombasthenia Therapeutic Drug Market Drivers
2.3.3 Glanzmann Thrombasthenia Therapeutic Drug Market Challenges
2.3.4 Glanzmann Thrombasthenia Therapeutic Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Revenue
3.1.1 Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Revenue (2016-2021)
3.1.2 Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Players (2016-2021)
3.2 Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Glanzmann Thrombasthenia Therapeutic Drug Revenue
3.4 Global Glanzmann Thrombasthenia Therapeutic Drug Market Concentration Ratio
3.4.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glanzmann Thrombasthenia Therapeutic Drug Revenue in 2020
3.5 Glanzmann Thrombasthenia Therapeutic Drug Key Players Head office and Area Served
3.6 Key Players Glanzmann Thrombasthenia Therapeutic Drug Product Solution and Service
3.7 Date of Enter into Glanzmann Thrombasthenia Therapeutic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Glanzmann Thrombasthenia Therapeutic Drug Breakdown Data by Type
4.1 Global Glanzmann Thrombasthenia Therapeutic Drug Historic Market Size by Type (2016-2021)
4.2 Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Type (2022-2027)

5 Glanzmann Thrombasthenia Therapeutic Drug Breakdown Data by Application
5.1 Global Glanzmann Thrombasthenia Therapeutic Drug Historic Market Size by Application (2016-2021)
5.2 Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
6.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
6.2.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
6.2.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
6.2.3 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
6.3 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
6.3.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
6.3.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
6.3.3 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
6.4 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
6.4.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021)
6.4.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
7.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
7.2.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
7.2.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
7.2.3 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
7.3 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
7.3.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
7.3.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
7.3.3 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
7.4 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
7.4.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021)
7.4.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
8.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
8.2.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
8.3.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region
8.4.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
9.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
9.2.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
9.2.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
9.2.3 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
9.3 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
9.3.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
9.3.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
9.3.3 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
9.4 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
9.4.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021)
9.4.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
10.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
10.2.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
10.3.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
10.4.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.1.4 Novo Nordisk Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.1.5 Novo Nordisk Recent Development
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Details
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.2.5 Alnylam Pharmaceuticals Recent Development
11.3 Shire (Takeda)
11.3.1 Shire (Takeda) Company Details
11.3.2 Shire (Takeda) Business Overview
11.3.3 Shire (Takeda) Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.3.4 Shire (Takeda) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.3.5 Shire (Takeda) Recent Development
11.4 Biogen
11.4.1 Biogen Company Details
11.4.2 Biogen Business Overview
11.4.3 Biogen Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.4.4 Biogen Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.4.5 Biogen Recent Development
11.5 Bioverativ (Sanofi)
11.5.1 Bioverativ (Sanofi) Company Details
11.5.2 Bioverativ (Sanofi) Business Overview
11.5.3 Bioverativ (Sanofi) Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.5.4 Bioverativ (Sanofi) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.5.5 Bioverativ (Sanofi) Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.6.4 Bayer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 CSL Behring
11.7.1 CSL Behring Company Details
11.7.2 CSL Behring Business Overview
11.7.3 CSL Behring Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.7.4 CSL Behring Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.7.5 CSL Behring Recent Development
11.8 Grifols
11.8.1 Grifols Company Details
11.8.2 Grifols Business Overview
11.8.3 Grifols Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.8.4 Grifols Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.8.5 Grifols Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.9.4 Bristol-Myers Squibb Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.10.4 Pfizer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.10.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ グランツマン血小板無力症治療薬の世界市場規模・現状・予測2021年-2027年(Global Glanzmann Thrombasthenia Therapeutic Drug Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。